08/10/2023 ET ONPATTRO (patisiran) - (APOLLO-B) $阿里拉姆制药(ALNY)$ $201.17 PDUFA date of October 8, 2023, with an advisory committee meeting planned for September 13, 2023.
13/10/2023 ET OPDIVO (nivolumab) - (Checkmate-76k) $百时美施贵宝(BMY)$ $62.02 PDUFA date on October 13, 2023.
网页链接{U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Supplemental Biologics License Application and European Medicines Agency Validates Application for Opdivo (nivolumab) …. | Business Wire}
16/10/2023 ET KEYTRUDA (pembrolizumab) in combination with chemotherapy - (KEYNOTE-671) $默沙东(MRK)$ $109.84 PDUFA date expected on October 16, 2023.
s21.q4cdn.com/488056881/files/doc_financials/2023/q2/2Q23-Earnings-Prepared-Remarks.pdf